A ground-breaking transport and time-release system that enables you to receive the products full health benefits Radically Advanced Formulations: Our CyLoc technology encases every nano molecule of active ingredient in a unique carrier, and pairs it with the DexKey release agent
For cosmeceutical formulators, this failure mode is not a dosing problem
Protocol approach 2: gut-focused autoimmune support (BPC-157 plus KPV) Goal: Restore gut barrier integrity and reduce intestinal inflammation Components: BPC-157 : 200-300 mcg twice daily, orally or subcutaneously near the abdomen (promotes mucosal healing, angiogenesis) KPV: 200-500 mcg daily, orally (NF-kB inhibition, cytokine reduction, PepT1-mediated gut absorption) Rationale: For autoimmune conditions with significant gastrointestinal involvement, including IBD, celiac-associated inflammation, or any autoimmune condition complicated by leaky gut, this combination addresses both the physical barrier damage (BPC-157) and the inflammatory signaling (KPV)
Adults 35 to 65 with systemic fatigue, slower recovery, and declining baseline energy not explained by other causes
